It is worth noting that this mitochondrial reprogramming mediated by ALDH2 is consistent with the broader metabolic adaptation in drug-resistant AML, in which the dependence on OXPHOS has been established as a marker of drug tolerance. The gene discussed is ALDH2; the disease is acute myeloid leukemia.